. LonzaGroup and ChrHansen Commit $101M to MicrobiomeBased Drug CDMO Venture httpow.lyCP5b30ojjGJÂpic.twitter.comamLLKSPNBY

. @LonzaGroup and @Chr_Hansen Commit $101M to #Microbiome-Based Drug CDMO Venture: http://ow.ly/CP5b30ojjGJ pic.twitter.com/amLLKSPNBY

12:25 EDT 6 Apr 2019 | Genetic Engineering News

. @LonzaGroup and @Chr_Hansen Commit $101M to #Microbiome-Based Drug CDMO Venture: http://ow.ly/CP5b30ojjGJ  pic.twitter.com/amLLKSPNBY

More From BioPortfolio on ". @LonzaGroup and @Chr_Hansen Commit $101M to #Microbiome-Based Drug CDMO Venture: http://ow.ly/CP5b30ojjGJ pic.twitter.com/amLLKSPNBY"